A selective serotonin reuptake inhibitor, citalopram, inhibits collagen-induced platelet aggregation and activation

Thrombosis Research

Volumn 126, Issue 6, 2010, Pages 517-523

  Tseng, Yu Lun ^a   Chiang, Meng Ling ^b   Huang, Tur Fu ^c   Su, Kuan Pin ^a,d   Lane, Hsien Yuan ^a,d   Lai, Yu Chen ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Aggregation; Citalopram; Collagen; Granules; Platelets; Thromboxane A 2

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ALPHA2BBETA3 INTEGRIN; CITALOPRAM; CONVULXIN; ELASTASE; FIBRINOGEN; INTEGRIN; IONOMYCIN; PADGEM PROTEIN; THROMBIN; THROMBOXANE A2; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME RELEASE; HEART PROTECTION; HUMAN; IN VITRO STUDY; INHIBITION KINETICS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

ANIMALS; BLOOD PLATELETS; CITALOPRAM; COLLAGEN; CYTOPLASMIC GRANULES; FIBRINOGEN; HUMANS; MICE; PLATELET ACTIVATION; PLATELET AGGREGATION; SEROTONIN UPTAKE INHIBITORS; SIGNAL TRANSDUCTION;

EID: 78649755193     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2010.09.017     Document Type: Article

References (37)

1. D.L. Musselman, D.L. Evans, and C.B. Nemeroff The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment Arch Gen Psychiatry 55 1998 580 592
2. W. Jiang, A. Glassman, R. Krishnan, C.M. O'Connor, and R.M. Califf Depression and ischemic heart disease: What have we learned so far and what must we do in the future? Am Heart J 150 2005 54 78
3. D.L. Musselman, A. Tomer, A.K. Manatunga, B.T. Knight, M.R. Porter, and S. Kasey Exaggerated platelet reactivity in major depression Am J Psychiatry 153 1996 1313 1317
4. R.C. Ziegelstein, K. Parakh, A. Sakhuja, and U. Bhat Depression and coronary artery disease: Is there a platelet link? Mayo Clin Proc 82 2007 1366 1368
5. E.C. Bruce, and D.L. Musselman Depression, alternation in platelet function, and ischemic heart disease Psychosom Med 67 suppl 1 2005 S34 S36
6. A.Y. Gasparyan, T. Watson, and G.Y. Lip The role of aspirin in cardiovascular prevention: implications of aspirin resistance J Am Coll Cardiol 51 2008 1829 1843
7. D. Shimbo, K.W. Davidson, D.C. Haas, V. Fuster, and J.J. Badimon Negative impact of depression on outcomes in patients with coronary artery disease: mechanisms, treatment considerations, and future directions J Thromb Haemost 3 2005 897 908
8. J.J.M.H. Strik, A. Honig, R. Lousberg, A.H.P. Lousberg, E.C. Cheriex, and H.G. Tuynman-Qua Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial Psychosom Med 62 2000 783 789
9. A.H. Glassman, C.M. O'Connor, R.M. Califf, K. Swedberg, P. Schwartz, and J.T. Bigger Jr. Sertraline treatment of major depression in patients with acute MI or unstable angina JAMA 288 2002 701 709
10. A.I. Malinin, S. Ong, L.M. Makarov, E.Y. Petukhova, and V.L. Serebruany Platelet inhibition beyond conventional antiplatelet agents: expanding role of angiotension receptor blockers, statins and selective serotonin reuptake inhibitors Int J Clin Pract 60 2006 993 1002
11. P. Blier, C. de Montigny, and Y. Chaput Modification of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression J Clin Psychopharmacol 7 6 Suppl 1987 24S 35S
12. D.T. Wong, F.P. Bymaster, J.S. Horng, and B.B. Molloy A new selective inhibitor for uptake of serotonin into synaptosomes of rat brain: 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine J Pharmacol Exp Ther 193 1975 804 811
13. C. Jonnakuty, and C. Gragnoli What do we know about serotonin? J Cell Physiol 217 2008 301 306
14. E. Maurer-Squrej Serotonin reuptake inhibitors and cardiovascular diseases: a platelet connection Cell Mol Life Sci 62 2005 159 170
15. E. Maurer-Squrej, K. Dyker, W.A. Gahl, and D.V. Devine A novel immunocytochemical assay for the detection of serotonin in platelets Br J Haematol 116 2002 604 611
16. N. Hergovich, M. Aigner, H.G. Eichler, J. Entlicher, C. Drucker, and B. Jilma Paroxetine decreases platelet serotonin storage and platelet function in human beings Clin Pharmacol Ther 68 2000 435 442
17. P. Blardi, A. de Lalla, R. Urso, A. Auteri, A. Dell'Erba, and L. Bossini Activity of citalopram on adenosine and serotonin circulating levels in depressed patients J Clin Psychopharmacol 25 2005 262 266
18. Z.M. Ruggeri Platelets in atherothrombosis Nat Med 8 2002 1227 1233
19. Y.L. Tseng, C.J. Lee, and T.F. Huang Effects of snake venom metalloproteinase, triflamp, on platelet aggregation, platelet-neutrophil and neutrophil-neutrophil interactions: involvement of platelet GPIbα and neutrophil PSGL-1 Thromb Haemost 91 2004 315 324
20. E. Komecki, Y.H. Ehrlich, D.D. De Mars, and R.H. Lenox Exposure of fibrinogen receptors in human platelets by surface proteolysis with elastase J Clin Invest 77 1986 750 756
21. C.Z. Liu, B.T. Hur, and T.F. Huang Measurement of glycoprotein IIb/IIIa blockade by flow cytometry with fluorescein isothiocyanate-conjugated crotavirin, a member of disintegrins Thromb Haemost 76 1996 585 591
22. W.R. Surin, M.K. Barthwal, and M. Dikshit Platelet collagen receptors, signaling and antagonism: Emerging approaches for the prevention of intravascular thrombosis Thromb Res 122 2008 786 803
23. 2, and adenosine diphosphate in collagen-induced platelet aggregation Blood 101 2003 2646 2651
24. D. Atar, A. Malinin, A. Takserman, A. Pokov, L. van Zyl, and J.F. Tanguay Escitalopram, but not its major metabolites, exhibits antiplatelet activity in humans J Clin Psychopharmacol 26 2006 172 177
25. D.J. McCloskey, T.T. Postolache, B.J. Vittone, K.L. Nghiem, J.L. Monsale, and R.A. Wesley Selective serotonin reuptake inhibitors: measurement of effect on platelet function Transl Res 151 2008 168 172
26. E. Maurer-Squrej, C. Pittendreigh, and K. Solomons The influence of selective serotonin reuptake inhibitors on human platelet serotonin Thromb Haemost 91 2004 119 128
27. V.L. Serebruany, P.A. Gurbel, and C.M. O'Connor Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors Pharmacol Res 43 2001 453 462
28. A. Cipriani, T.A. Furukawa, G. Salanti, J.R. Geddes, J.P.T. Higgins, and R. Churchill Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis Lancet 373 2009 746 758
29. J. Hyttei Citalopram-Pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity Prog Neuropsychopharmacol Biol Psychiatry 6 1982 277 295
30. D. Atar, A. Malinin, A. Pokov, L. van Zyl, N. Frasure-Smith, and F. Lesperance Antiplatelet properties of escitalopram in patients with the metabolic syndrome: A dose-ranging in vitro study Neuropsychopharmacology 32 2007 2369 2374
31. T.W. Chow, J.D. Hellums, J.L. Moake, and M.H. Kroll Shear stress-induced von Willebrand factor binding to platelet glycoprotein Ib initiates calcium influx associated with aggregation Blood 80 1992 113 120
32. T.F. Huang, C.Z. Liu, and S.H. Yang Aggretin, a novel platelet-aggregation inducer from snake (Calloselasma ehodostoma) venom, activates phospholipase C by acting as a glycoprotein Ia/IIa agonist Biochem J 309 1995 1021 1027
33. 3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans J Clin Invest 118 2008 1544 1552
34. 2 release J Biol Chem 281 2006 30024 30035
35. J.A. Steiner, A.M.D. Carneiro, and R.D. Blakely Going with the flow: Trafficking-dependent and independent regulation of serotonin transport Traffic 9 2008 1393 1402
36. P. Joffe, F.S. Larsen, V. Pedersen, H. Ring-Larsen, T. Aaes-Jørgensen, and J. Sidhu Single-dose pharmacokinetics of citalopram in patients with moderate renal insufficiency or hepatic cirrhosis compared with healthy subjects Eur J Clin Pharmacol 54 1998 237 242
37. R. Oruch, E. Hodneland, I.F. Pryme, and H. Holmsen In thrombin stimulated human platelets citalopram, promethazine, risperidone, and ziprasidone, but not diazepam, may exert their pharmacological effects also through intercalation in membrane phospholipids in a receptor-independent manner J Chem Biol 2 2009 89 103